Budesonide-Loaded Hyaluronic Acid Nanoparticles for Targeted Delivery to the Inflamed Intestinal Mucosa in a Rodent Model of Colitis

Figure 2

Photographs of the colon of rat after the induction of colitis with acetic acid sacrificed on day 7: (a) (sham or normal group; group I), (b) (untreated acetic acid group; group V), (c) (blank nanoparticles treated group; group II), (d) (budesonide suspension treated group; group III), (e) (budesonide-loaded HA nanoparticle treated group; group IV).

(a)

(b)

(c)

(d)

(e)